shutterstock_273326141

Bristol Myers Squibb pays $475 million for exclusive rights to Dragonfly Therapeutics’ IL-12 immunotherapy programme

August 18, 2020
Manufacturing and Production, Sales and Marketing Bristol Myers Squib, Drgonfly Therapeutics, pharma, pharma deal

Bristol Myers Squibb has scooped up the sole rights to the interleukin-12 (IL-12) immunotherapy programme of Massachusetts-based biotech Dragonfly Therapeutics, …

trummmuuuue

Trump allegedly “enthusiastic” for oleandrin to be approved as a COVID-19 treatment

August 18, 2020
Manufacturing and Production, Research and Development coronavirus vaccine, covid19

President Donald Trump reportedly wants to approve Phoenix Biotechnology’s oleandrin as a coronavirus treatment, despite a lack of evidence for …

shutterstock_36423250

China approves its first biosimilar of Roche’s Herceptin in HER2+ cancers

August 18, 2020
Manufacturing and Production, Sales and Marketing China, Henlius, Herceptin, Roche, biosimilar

China’s National Medical Products Administration (NMPA) has given the green light to Shanghai’s Henlius for its biosimilar version of Roche’s …

cbdx

NHS guidelines on prescription cannabis to be challenged in court

August 18, 2020
Manufacturing and Production, Research and Development CBD, cannabis, epilepsy

The cannabis guidelines followed by the NHS are set to be challenged in court by the parents of a three-year-old …

transportation_isolation_system

China’s drug regulator says vaccines must have 50 percent efficacy to be approved

August 17, 2020
Sales and Marketing COVID, China, coronavirus, vaccines

The Chinese Centre for Drug Evaluation (CCDE) has said that coronavirus vaccines must show 50 percent efficacy to be approved.  …

cokc

Public Health England set to be replaced by a new agency to specifically deal with pandemics

August 17, 2020
Sales and Marketing COVID, Public Health England, pandemic, phe

Public Health England is set to be replaced with a new agency to prepare the country to deal with future …

23814734268_1b63909bf3_z

Amazon Pharmacy launches in India

August 17, 2020
Sales and Marketing India, amazon, pharma

Amazon has entered the pharmaceutical market by launching ‘Amazon Pharmacy’ in India. 

6127242068_23c80ef94f_b

Sanofi to buy Principia Biopharma for $3.4 billion

August 17, 2020
Sales and Marketing MS, Sanofi

Sanofi is set to buy California based Principia Biopharma in a deal that is worth $3.4 billion. This deal means …

fda_23

FDA approves Roche’s Enspryng for neuromyelitis optica

August 17, 2020
Sales and Marketing COVID, COVID-19, coronavirus

The FDA has granted approval for Roche’s Enspryng for treating the central nervous system disorder neuromyelitis optica. The drug (satralizumab) …

fda2outsideweb

FDA panel votes 9-1 in favour of approval for Mesoblast’s Ryoncil in paediatric steroid-refractory acute graft versus host disease

August 14, 2020
Medical Communications, Sales and Marketing FDA, Mesoblast, Ryoncil, pharma

It’s good news for Mesoblast as an expert FDA panel gave a glowing recommendation for the approval in the US …

fillip

Philippines expected to approve Russia’s ‘Sputnik’ COVID-19 vaccine

August 14, 2020
Medical Communications COVID, COVID-19, coronavirus, vaccines

The Philippines is expected to begin large scale human testing of Russia’s controversial ‘Sputnik’ coronavirus vaccine. Rodrigo Duterte, the President …

shutterstock_244903099

Novavax and Janssen commit 90 million COVID-19 vaccine doses to UK Government with two new deals

August 14, 2020
Manufacturing and Production, Medical Communications, Sales and Marketing COVID-19, J&J, JJ, Novavax, UK, pharma

The UK Government has signed a new deal with Johnson & Johnson and Novavax to secure 90 million orders of …

vxxxxeer_0

Top Russian doctor quits over questionable ethics that rushed through coronavirus vaccine approval

August 14, 2020
Medical Communications

Professor Alexander Chuchalin has quit the Russian Health Ministry’s ethics council due to the quick approval process for the country’s …

top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

August 14, 2020
Medical Communications COVID-19, coronavirus, pandemic

The top 10 news stories this week once again focus on coronavirus treatments and vaccines, as President Putin announced that …

truvada-web

Gilead’s Truvada becomes first China-approved drug to prevent HIV-1

August 13, 2020
Sales and Marketing China, Truvada, approval. HIV

China’s National Medical Products Administration (NMPA) has awarded approval to Gilead’s Truvada in a pre-exposure prophylaxis (PrEP) indication to prevent …

MHRA designates cenobamate as a Promising Innovative Medicine for treating drug resistant seizures

August 13, 2020
Research and Development MHRA, cenobamate, seizures

Arvelle Therapeutics has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has given their anti-seizure medication (cenobamate) …

800px-thumbnail

COVID-19 patients are experiencing long-term effects from the virus

August 13, 2020
COVID, COVID-19, coronavirus

Almost a third of doctors have treated patients for long-term symptoms caused by coronavirus, according to a new study.

FDA approves NS Pharma’s Viltepso for Duchenne muscular dystrophy, but concerns over benefit persist

August 13, 2020
Sales and Marketing Duchenne Muscular Dystrophy, FDA, NS pharma, Viltepso

NS Pharma has claimed a tentative FDA approval for its Viltepso (viltolarsen) injection in the treatment of Duchenne muscular dystrophy …

fake_news

Coronavirus fake news has led to hundreds of deaths, according to a new study

August 13, 2020
Medical Communications COVID, coronavirus, fake news

At least 800 people have died around the world from COVID-19 misinformation in the first three months of 2020, according …

shutterstock_158366573

Racial minority groups are not adequately represented in COVID-19 clinical studies, research argues

August 12, 2020
Research and Development COVID-19, Gilead, pharma, remdesivir

New research has warned that minority groups and people of colour are underrepresented in current trials for COVID-19 therapies, despite …

The Gateway to Local Adoption Series

Latest content